The ROC curves predicting 2-, 4-, and 5-year survival of patients with NPC are shown in Figure 7E. Among the differentially expressed metabolic genes in panCK and CD45 regions, MDH1 which has the most obvious prognostic effect was selected for validation. This evidence concerns the gene MDH1 and nasopharyngeal carcinoma.